FDA doubles down on warfarin test strip recall

This article was originally published here

FDA-logo-newThe FDA this week alerted patients and doctors about test strips used to monitor levels of the blood thinner warfarin, expanding and reiterating its warning that the products shouldn’t be used to adjust a person’s drug dosage.

The agency’s latest notice is related to the Class I recall of Roche‘s CoaguChek meters and test strips, which the FDA issued in November last year. The initial recall involved more than 1.1 million packages of CoaguChek XS PT test strips that were distributed across the U.S. from Jan. 12 – Oct. 29 of 2018.

Get the full story at our sister site, Drug Delivery Business News.

The post FDA doubles down on warfarin test strip recall appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply